Please login to the form below

Not currently logged in
Email:
Password:

#GDPR

This page shows the latest #GDPR news and features for those working in and with pharma, biotech and healthcare.

Safety first: AI adoption in the healthcare sector

Safety first: AI adoption in the healthcare sector

The GDPR introduced a right to explanation, which means that the logic of an automated decision can be challenged and the results tested – businesses will need to think carefully before building ... Where required by the GDPR, privacy impact

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Stepping up in social media: trust and participation are the new imperatives Stepping up in social media: trust and participation are the new imperatives

    And what are the rules of engagement? Trust is the name of the game: in the wake of the Cambridge Analytica scandal and with  GDPR coming into force in May, we

  • Protecting patient privacy Protecting patient privacy

    With the EU’s new General Data Protection Regulation (GDPR) now imminent, the impetus for life science firms to cement their data management strategies has further increased. ... Managed service providers will also keep abreast of data security as they

  • A new era of smart pharma A new era of smart pharma

    Also worth considering is the effect that regulations, specifically GDPR, will have on these developments. ... GDPR’s stipulation that patients who grant companies the use of their data can withdraw consent at any time and have it deleted (‘right to

  • Risky business for pharma Risky business for pharma

    Regulation (GDPR).

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    The European General Data Protection Regulation (GDPR) is scheduled to come into force in 2018, requiring life science companies to develop models for HCP consent and preference management. ... Violations of the GDPR can be costly, reaching as high as 4%

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics